Selected research
Industry Research
Biopharmaceutical Excipients Industry Research Report 2026
Market perspective
The global Biopharmaceutical Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biopharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biopharmaceutical Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biopharmaceutical Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biopharmaceutical Excipients include BASF SE, ABITEC Corp, Colorcon, Inc, DFE Pharma, Meggle AG, Pharmonix Biological, Roquette, Sigachi Industries and Signet Chemical Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biopharmaceutical Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biopharmaceutical Excipients Market by Company
BASF SE
ABITEC Corp
Colorcon, Inc
DFE Pharma
Meggle AG
Pharmonix Biological
Roquette
Sigachi Industries
Signet Chemical Corporation
Spectrum Chemical Manufacturing Corp
SPI Pharma
Biopharmaceutical Excipients Segment by Type
Polyols
Carbohydrates
Solubilizers& Surfactants/Emulsifiers
Other
Biopharmaceutical Excipients Segment by Application
Biopharmaceutical Downstream
Biopharmaceutical Upstream
Biopharmaceutical Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biopharmaceutical Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biopharmaceutical Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biopharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyols
- Carbohydrates
- Solubilizers& Surfactants/Emulsifiers
- Other
Applications
- Biopharmaceutical Downstream
- Biopharmaceutical Upstream
Companies covered
- BASF SE
- ABITEC Corp
- Colorcon, Inc
- DFE Pharma
- Meggle AG
- Pharmonix Biological
- Roquette
- Sigachi Industries
- Signet Chemical Corporation
- Spectrum Chemical Manufacturing Corp
- SPI Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biopharmaceutical Excipients Market Size (2021-2032)
- 2.2.2 Global Biopharmaceutical Excipients Sales (2021-2032)
- 2.2.3 Global Biopharmaceutical Excipients Market Average Price (2021-2032)
- 2.3 Biopharmaceutical Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyols
- 2.3.3 Carbohydrates
- 2.3.4 Solubilizers& Surfactants/Emulsifiers
- 2.3.5 Other
- 2.4 Biopharmaceutical Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Biopharmaceutical Downstream
- 2.4.3 Biopharmaceutical Upstream
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biopharmaceutical Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biopharmaceutical Excipients Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Biopharmaceutical Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Biopharmaceutical Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Biopharmaceutical Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biopharmaceutical Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biopharmaceutical Excipients, Product Type & Application
- 3.8 Global Manufacturers of Biopharmaceutical Excipients, Established Date
- 3.9 Global Biopharmaceutical Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF SE
- 4.1.1 BASF SE Company Information
- 4.1.2 BASF SE Business Overview
- 4.1.3 BASF SE Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BASF SE Biopharmaceutical Excipients Product Portfolio
- 4.1.5 BASF SE Recent Developments
- 4.2 ABITEC Corp
- 4.2.1 ABITEC Corp Company Information
- 4.2.2 ABITEC Corp Business Overview
- 4.2.3 ABITEC Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ABITEC Corp Biopharmaceutical Excipients Product Portfolio
- 4.2.5 ABITEC Corp Recent Developments
- 4.3 Colorcon, Inc
- 4.3.1 Colorcon, Inc Company Information
- 4.3.2 Colorcon, Inc Business Overview
- 4.3.3 Colorcon, Inc Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Colorcon, Inc Biopharmaceutical Excipients Product Portfolio
- 4.3.5 Colorcon, Inc Recent Developments
- 4.4 DFE Pharma
- 4.4.1 DFE Pharma Company Information
- 4.4.2 DFE Pharma Business Overview
- 4.4.3 DFE Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DFE Pharma Biopharmaceutical Excipients Product Portfolio
- 4.4.5 DFE Pharma Recent Developments
- 4.5 Meggle AG
- 4.5.1 Meggle AG Company Information
- 4.5.2 Meggle AG Business Overview
- 4.5.3 Meggle AG Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Meggle AG Biopharmaceutical Excipients Product Portfolio
- 4.5.5 Meggle AG Recent Developments
- 4.6 Pharmonix Biological
- 4.6.1 Pharmonix Biological Company Information
- 4.6.2 Pharmonix Biological Business Overview
- 4.6.3 Pharmonix Biological Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pharmonix Biological Biopharmaceutical Excipients Product Portfolio
- 4.6.5 Pharmonix Biological Recent Developments
- 4.7 Roquette
- 4.7.1 Roquette Company Information
- 4.7.2 Roquette Business Overview
- 4.7.3 Roquette Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Roquette Biopharmaceutical Excipients Product Portfolio
- 4.7.5 Roquette Recent Developments
- 4.8 Sigachi Industries
- 4.8.1 Sigachi Industries Company Information
- 4.8.2 Sigachi Industries Business Overview
- 4.8.3 Sigachi Industries Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sigachi Industries Biopharmaceutical Excipients Product Portfolio
- 4.8.5 Sigachi Industries Recent Developments
- 4.9 Signet Chemical Corporation
- 4.9.1 Signet Chemical Corporation Company Information
- 4.9.2 Signet Chemical Corporation Business Overview
- 4.9.3 Signet Chemical Corporation Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Signet Chemical Corporation Biopharmaceutical Excipients Product Portfolio
- 4.9.5 Signet Chemical Corporation Recent Developments
- 4.10 Spectrum Chemical Manufacturing Corp
- 4.10.1 Spectrum Chemical Manufacturing Corp Company Information
- 4.10.2 Spectrum Chemical Manufacturing Corp Business Overview
- 4.10.3 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Spectrum Chemical Manufacturing Corp Biopharmaceutical Excipients Product Portfolio
- 4.10.5 Spectrum Chemical Manufacturing Corp Recent Developments
- 4.11 SPI Pharma
- 4.11.1 SPI Pharma Company Information
- 4.11.2 SPI Pharma Business Overview
- 4.11.3 SPI Pharma Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SPI Pharma Biopharmaceutical Excipients Product Portfolio
- 4.11.5 SPI Pharma Recent Developments
5 Global Biopharmaceutical Excipients Market Scenario by Region
- 5.1 Global Biopharmaceutical Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biopharmaceutical Excipients Sales by Region: 2021-2032
- 5.2.1 Global Biopharmaceutical Excipients Sales by Region: 2021-2026
- 5.2.2 Global Biopharmaceutical Excipients Sales by Region: 2027-2032
- 5.3 Global Biopharmaceutical Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Biopharmaceutical Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Biopharmaceutical Excipients Revenue by Region: 2027-2032
- 5.4 North America Biopharmaceutical Excipients Market Facts & Figures by Country
- 5.4.1 North America Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biopharmaceutical Excipients Sales by Country (2021-2032)
- 5.4.3 North America Biopharmaceutical Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Biopharmaceutical Excipients Market Facts & Figures by Country
- 5.5.1 Europe Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biopharmaceutical Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Biopharmaceutical Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Biopharmaceutical Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biopharmaceutical Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biopharmaceutical Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biopharmaceutical Excipients Market Facts & Figures by Country
- 5.7.1 South America Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biopharmaceutical Excipients Sales by Country (2021-2032)
- 5.7.3 South America Biopharmaceutical Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Biopharmaceutical Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biopharmaceutical Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biopharmaceutical Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biopharmaceutical Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Biopharmaceutical Excipients Sales by Type (2021-2032)
- 6.1.1 Global Biopharmaceutical Excipients Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Biopharmaceutical Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Biopharmaceutical Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Biopharmaceutical Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Biopharmaceutical Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biopharmaceutical Excipients Sales by Application (2021-2032)
- 7.1.1 Global Biopharmaceutical Excipients Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Biopharmaceutical Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Biopharmaceutical Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Biopharmaceutical Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biopharmaceutical Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Biopharmaceutical Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biopharmaceutical Excipients Value Chain Analysis
- 8.1.1 Biopharmaceutical Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biopharmaceutical Excipients Production Mode & Process
- 8.2 Biopharmaceutical Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biopharmaceutical Excipients Distributors
- 8.2.3 Biopharmaceutical Excipients Customers
9 Global Biopharmaceutical Excipients Analyzing Market Dynamics
- 9.1 Biopharmaceutical Excipients Industry Trends
- 9.2 Biopharmaceutical Excipients Industry Drivers
- 9.3 Biopharmaceutical Excipients Industry Opportunities and Challenges
- 9.4 Biopharmaceutical Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst